HeatherChengMDPhD

PubMed

• 2 citations
  Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review.
  Edoardo Francini, Neeraj Agarwal, Elena Castro, Heather H Cheng, Kim N Chi
  European Urology. 2025-01-01
• Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer.
  Francesca Zacchi, Wassim Abida, Emmanuel S Antonarakis, Alan H Bryce, Elena Castro
  European Urology Oncology. 2024-12-04
• 1 citations
  SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer ReceivingLu-PSMA-617.
  Ridvan Arda Demirci, Roman Gulati, Jessica E Hawley, Todd Yezefski, Michael C Haffner
  Journal of Nuclear Medicine. 2024-12-03

Journal Articles

• Association of Clonal Hematopoiesis in DNA Repair Genes with Prostate Cancer Plasma Cell-Free DNA Testing Interference  
  Michael T Schweizer, Petros Grivas, Heather H Cheng, Evan Y Yu, JAMA Oncology
• Undetectable Prostate‐Specific Antigen After Short‐Course Androgen Deprivation Therapy for Biochemically Recurrent Patients Correlates with Metastasis‐Free Survival an...  
  Heather H Cheng, Jonathan T Wingate, Evan Y Yu, The Prostate
• Role of maximal endoscopic resection prior to cystectomy for invasive urothelial bladder cancer  
  James, A.C., Lee, F.C., Izard, J.P., Harris, W.P., Cheng, H.H., Zhao, S., Gore, J.L., Lin, D.W., Porter, M.P., Yu, E.Y., Wright, J.L., Clinical Genitourinary Cancer, 1/23/2014
• Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence for Cancer-Associated Hypoxia  
  Cheng, H.H.*, Mitchell, P.S.*, Kroh, E., Dowell, A.E., Chéry, L., Siddique J., Nelson, P.S., Vessella, R., Knudsen, B.S., Chinnaiyan, A.M., Pienta, K.J., Morrissey, C...., PLoS ONE, 1/1/2013
• Into Thin Air: New Insights to the Role of Hypoxia-Inducible Factor in Cancer Biology and as a Target to Optimize Cell-Based Therapies  
  Cheng, H.H. and Linenberger, M., The Hematologist, 1/1/2011
• Join now to see all

Books/Book Chapters

• Management of Castration Resistant Prostate Cancer 
  Chapter: Androgen Receptor Biology in Castration Resistant Prostate Cancer 
  Cheng, H.H. and Montgomery, R.B.Springer Science+Media, New York, NY2015

Abstracts/Posters

• Inherited Mutations in DNA Repair Genes in Men with Metastatic Castration Resistant Prostate Cancer
  Nelson, P.S., Mateo, J., Beltran, H., De Sarkar, N., Elemento, O., Rubin, M.A., Vinson, J.N., Filipenko, J., Robinson, D.R., Chinnaiyan, A.M., Van Allen, E.M., Garofal..., ASCO Annual Meeting, 1/1/2016
• Impact of prior definitive therapy on survival outcomes in men with new hormone sensitive metastatic prostate cancer (mHSPC)
  Alex, A., Stenehjem, D.D., Twardowski, P., Cheng, H.H., Gill, D.M., Buckley, T.H., Patel, S.B., Kessler, E.R., Chittoria, N., Vaishampayan, U.N., Agarwal, N., Genitourinary Oncology Symposium; American Society of Clinical Oncology Annual Meeting, San Francisco, CA, 2015, 1/1/2016
• Screening men at increased risk for prostate cancer diagnosis
  Gulati, R., Cheng, H.H., Lange, P.H., Nelson, P.S., Etzioni, R, 38th Annual North American Meeting of the Society for Medical Decision Making, Vancouver, Canada, 1/1/2016
• Biallelic inactivation of BRCA2 in metastatic castration resistant prostate cancer is associated with platinum sensitivity
  Cheng, H.H., Pritchard, C.C., Boyd, T., Nelson, P.S., Montgomery, R.B., 6th International PacRim Breast and Prostate Cancer Meeting, Stevenson, WA, 1/21/2015
• Treatment and survival in young men under age 55 years diagnosed with Gleason 8-10 Prostate Cancer: Implications for PSA screening
  Winters, B., Holt, S., Lin, D., Porter, M., Cheng, H., Wright, J., American Urological Association, 1/1/2015
• Biallelic inactivation of BRCA2 in metastatic castration resistant prostate cancer and platinum sensitivity
  Cheng, H.H., Pritchard, C.C., Nelson, P.S., Montgomery, R.B., Genitourinary Oncology Symposium, San Francisco, CA, 1/1/2015
• Pilot study of clinical targeted next generation sequencing for prostate cancer: consequences for treatment and genetic counseling
  Cheng, H.H., Klemfuss, N., Montgomery, R.B., Higano, C.S., Schweizer, M.T., Mostaghel, E.A., Yu, E.Y., Nelson, P.S., Pritchard, C.C., Genitourinary Oncology Symposium, San Francisco, CA, 1/1/2015
• Circulating Biomarkers in Advanced Disease
  Cheng, H.H., Institute for Prostate Cancer Research Symposium, Fred Hutchinson Cancer Research Center, 1/12/2014
• The Effect of Prior Abiraterone (Abi) Use on the Efficacy of Enzalutamide (Enza) in Men with mCRPC
  Cheng, H.H., Nadal, R., Gulati, R., Azad, A., Twardowski, P., Vaishampayan, U., Agarwal, N., Heath, E., Pal, S.K., Rehman, H., Leiter, A., Batten, J., Montgomery, R.B...., Genitourinary Cancers Symposium, American Society of Clinical Oncology, 1/1/2014
• Comparison of plasma microRNAs with CTCs and PSA in patients treated on SWOG S0925, a randomized phase II study of androgen deprivation combined with cixutumumab versu...
  Cheng, H.H., Tangen, C.M., Higano, C.S., Li, H., Agarwal, N., Yan, J., Vogelzang, N.J., Hussain, M., Thompson, I.M., Tewari, M., Yu, E.Y., American Society of Clinical Oncology Annual Meeting, 1/1/2014
• Improving Efficiency and Accuracy in Medical Records Review for Clinical Care, Clinical Trials and Clinical Database in Genitourinary Medical Oncology (GUMO) Through B...
  Nguyen, H., Gawne, A., Taub, J., Soleau, C., Teller, S., So, M., and Cheng, H., Solid Tumor Translational Research Process Improvement Project, Oncology Recognition Day, 1/1/2014
• A pilot study of high-dose exisulind in men with biochemical relapse (BCR) of prostate cancer after definitive local therapy treated with intermittent androgen depriva...
  Yu, E.Y., Kuo, K.F., Hunter-Merrill, R., Gulati, R., Cheng, H.H., Flamiatos, J.F., Gambol, T.E., Hall, S.P., Higano, C.S., Genitourinary Cancers Symposium, American Society of Clinical Oncology, 1/1/2013
• Pathologic response rates between gemcitabine-cisplatin (GC) and methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) neoadjuvant chemotherapy in muscle invasiv...
  Wright, J.L., Lee, F., Harris, W.P., Cheng, H.H., Zhao, S., Champion, T., Dean, J., Gore, J.L. Porter, M.P., Yu, E.Y., Genitourinary Cancers Symposium, Americal Society of Clinical Oncology, 1/1/2013
• Circulating miRNAs as Clinically Meaningful Classifiers of Castration-Resistant Prostate Cancers
  Aparicio, A., Gallichotte, E., Cheng, H., Maity, S., Logothetis, Yoo, S.-Y., Baggerly, K., Tewari, M., American Association for Cancer Research Annual Meeting, 1/1/2013
• Circulating microRNA biomarkers for cancer exist in multiple biophysical states
  Chevillet, J.R., Gallichotte, E., Cheng, H.H., Vojtech, L.N., Arroyo, J.D., Briggs, H., Vessella, R.L., Higano, C.S., Yu, E.Y., Pogosova-Agadjanyan, E.L., Stirewalt, D..., Cancer Research, 1/1/2013
• Candidate Circulating MicroRNA Cancer Biomarkers Are Altered Up To One Thousand-Fold By Blood Sample Processing
  Cheng, H.H., Yi, H.Y., Tewari, M., Pritchard, C.C., ASCO/EORTC/NCI Markers in Cancer, Hollywood, FL, 1/1/2012
• Join now to see all

Lectures

• The GENTleMEN study: Genetic testing for men with metastatic prostate cancer in Washington state and beyond. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Genomics Versus Genetics and Implications for Prostate Cancer Care 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
• Emerging Therapies in Cancer: Cancer Genetics 
  Mount Vernon, WA - 1/29/2016
• Germline DNA Repair Gene Mutations in Metastatic Prostate Cancer 
  Coronado, CA - 1/24/2016
• Lessons from Breast Cancer: How Genes May Affect Risk, Treatment and Outcomes in Prostate Cancer 
  Fred Hutchinson Cancer Research Center - 1/11/2015
• Prostate Cancer: Progress Made and Research in Progress 
  Seattle Cancer Care Alliance, Seattle, WA - 1/7/2015
• Recent Developments and Clinical Trials in Prostate Cancer 
  Seattle, WA - 1/20/2014
• The Surprising Ways in Which Patients Shape our Lives 
  Seattle Cancer Care Alliance - 1/12/2014
• Comparison of plasma microRNAs with CTCs and PSA in patients treated on SWOG S0925 
  1/1/2014
• SWOG S0925: A randomized phase 2 study of androgen deprivation combined with cixutumumab (IMC-A12) versus androgen deprivation alone for patients with new metastatic c... 
  1/1/2014
• Prostate Cancer: New Treatments and Ongoing Research 
  NW African American Museum, Seattle, WA - 1/25/2013
• Determinants of Receptor Specificity for Feline Leukemia Virus Variants 
  Cold Spring Harbor, NY - 1/1/2003
• Identifying the Requirements and Mechanisms of FeLV-T Entry 
  Indian Wells, CA - 1/1/2002
• Join now to see all